JP2023071952A5 - - Google Patents
Info
- Publication number
- JP2023071952A5 JP2023071952A5 JP2023035901A JP2023035901A JP2023071952A5 JP 2023071952 A5 JP2023071952 A5 JP 2023071952A5 JP 2023035901 A JP2023035901 A JP 2023035901A JP 2023035901 A JP2023035901 A JP 2023035901A JP 2023071952 A5 JP2023071952 A5 JP 2023071952A5
- Authority
- JP
- Japan
- Prior art keywords
- chelating agent
- composition
- inhalable composition
- dose
- inhalable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017902365 | 2017-06-20 | ||
| AU2017902365A AU2017902365A0 (en) | 2017-06-20 | Method For Reducing Lung Inflammation | |
| PCT/AU2018/050609 WO2018232452A1 (en) | 2017-06-20 | 2018-06-20 | METHOD FOR REDUCING PULMONARY INFLAMMATION |
| JP2019571349A JP7729713B2 (ja) | 2017-06-20 | 2018-06-20 | 肺炎症を低減させる方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571349A Division JP7729713B2 (ja) | 2017-06-20 | 2018-06-20 | 肺炎症を低減させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023071952A JP2023071952A (ja) | 2023-05-23 |
| JP2023071952A5 true JP2023071952A5 (enExample) | 2025-11-13 |
| JP7848150B2 JP7848150B2 (ja) | 2026-04-20 |
Family
ID=64735378
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571349A Active JP7729713B2 (ja) | 2017-06-20 | 2018-06-20 | 肺炎症を低減させる方法 |
| JP2023035901A Active JP7848150B2 (ja) | 2017-06-20 | 2023-03-08 | 肺炎症を低減させる方法 |
| JP2025031885A Withdrawn JP2025098035A (ja) | 2017-06-20 | 2025-02-28 | 肺炎症を低減させる方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571349A Active JP7729713B2 (ja) | 2017-06-20 | 2018-06-20 | 肺炎症を低減させる方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025031885A Withdrawn JP2025098035A (ja) | 2017-06-20 | 2025-02-28 | 肺炎症を低減させる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11491126B2 (enExample) |
| EP (1) | EP3641749A4 (enExample) |
| JP (3) | JP7729713B2 (enExample) |
| CN (1) | CN111050762A (enExample) |
| AU (2) | AU2018286649B2 (enExample) |
| BR (1) | BR112019027257A2 (enExample) |
| CA (1) | CA3067857A1 (enExample) |
| WO (1) | WO2018232452A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI818601B (zh) * | 2021-10-29 | 2023-10-11 | 原創生醫股份有限公司 | 用於上呼吸道給藥之組成物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| EP2152304B1 (en) | 2007-05-02 | 2018-08-22 | The Regents of the University of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| CA2982943C (en) * | 2015-03-11 | 2019-07-23 | University Of Cincinnati | Compositions and methods for treating bacterial infection |
| EP3383415B1 (en) * | 2015-12-01 | 2021-03-31 | Cornell University | Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease |
-
2018
- 2018-06-20 WO PCT/AU2018/050609 patent/WO2018232452A1/en not_active Ceased
- 2018-06-20 CN CN201880041015.9A patent/CN111050762A/zh active Pending
- 2018-06-20 US US16/615,075 patent/US11491126B2/en active Active
- 2018-06-20 EP EP18820998.5A patent/EP3641749A4/en active Pending
- 2018-06-20 CA CA3067857A patent/CA3067857A1/en active Pending
- 2018-06-20 BR BR112019027257-7A patent/BR112019027257A2/pt not_active Application Discontinuation
- 2018-06-20 AU AU2018286649A patent/AU2018286649B2/en active Active
- 2018-06-20 JP JP2019571349A patent/JP7729713B2/ja active Active
-
2022
- 2022-09-28 US US17/936,058 patent/US20230045633A1/en active Pending
-
2023
- 2023-03-08 JP JP2023035901A patent/JP7848150B2/ja active Active
- 2023-11-23 AU AU2023270302A patent/AU2023270302B2/en active Active
-
2025
- 2025-02-28 JP JP2025031885A patent/JP2025098035A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001036A5 (enExample) | ||
| RU2010150839A (ru) | Внутрилегочное введения флуорохинолона | |
| JP2011520911A5 (enExample) | ||
| HRP20210704T1 (hr) | Formulacija suhog praška koja sadrži antikolinergik, kortikosteroid i beta-adrenergik za davanje inhalacijom | |
| CN102325532B (zh) | 用于减轻肺部炎症的左氧氟沙星吸入剂 | |
| RU2019100425A (ru) | Новая доза и препаративная форма | |
| CA2421974A1 (en) | Pulmonary delivery in treating disorders of the central nervous system | |
| JP2015519404A5 (enExample) | ||
| CO6260019A2 (es) | Metodos para el tratamiento de desordenes gastrointestinales independientes de la ingesta de alimento | |
| JP2013503907A5 (enExample) | ||
| US20090169487A1 (en) | Essential Oil Diffusion | |
| WO2015014209A1 (zh) | 稳定渗透压的丙酮酸药物组成及其在健康人和肺病病人中的排毒作用 | |
| US20060134008A1 (en) | Compositions and methods for pulmonary conditions | |
| WO2021212183A1 (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
| JP2020524172A5 (enExample) | ||
| JP2015522015A5 (enExample) | ||
| Parameswara | Anesthetic Concerns in Patients with Hyper‑reactive Airways | |
| Poulakou et al. | Inhaled antimicrobials for ventilator-associated pneumonia: practical aspects | |
| JP2021535163A5 (enExample) | ||
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| WO2008143892A9 (en) | Method of treating tuberculosis with interferons | |
| CN1230199C (zh) | 氧化氮用于气道狭窄治疗的用途 | |
| RU2191024C1 (ru) | Ингаляционный препарат, купирующий удушье при бронхиальной астме и бронхоспазме | |
| CN112957350A (zh) | 一种鱼腥草雾化吸入用溶液制剂及其制备方法 | |
| RU2766246C1 (ru) | Способ лечения и реабилитации больных после острых респираторных вирусных инфекций |